Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis

Autor: Genovese, Mark C *, Smolen, Josef S, Takeuchi, Tsutomu, Burmester, Gerd, Brinker, Dennis, Rooney, Terence P, Zhong, Jinglin, Daojun, Mo, Saifan, Chadi, Cardoso, Anabela, Issa, Maher, Wu, Wen-Shuo, Winthrop, Kevin L
Zdroj: In The Lancet Rheumatology June 2020 2(6):e347-e357
Databáze: ScienceDirect